<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02827435</url>
  </required_header>
  <id_info>
    <org_study_id>Roc_KTPL_PKPD</org_study_id>
    <nct_id>NCT02827435</nct_id>
  </id_info>
  <brief_title>Acute Pharmacokinetic-pharmacodynamic Change of Rocuronium After Reperfusion of Renal Graft</brief_title>
  <official_title>Acute Pharmacokinetic-pharmacodynamic Change of Rocuronium After Reperfusion of Renal Graft During Kidney Transplantation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Seoul National University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Seoul National University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Reperfusion of renal graft in kidney transplantation can change the
      pharmacokinetic-pharmacodynamic (PKPD) parameters of rocuronium. The immediate increase of
      urine output during surgery may change the PKPD parameters of the drugs, including
      elimination rate. The goal of this study is to characterize the PKPD model of rocuronium
      during kidney transplantation and establish a basis for adequate dosage of rocuronium in
      kidney transplantation.

      Through PKPD modeling, the changes during reperfusion of the renal graft will be evaluated.
      Furthermore, the factors related to the changes will be assessed. Adjusting the infusion rate
      according to the step of kidney transplantation will lead to stable muscle relaxation and
      fast recovery.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>July 2016</start_date>
  <completion_date type="Anticipated">July 2017</completion_date>
  <primary_completion_date type="Anticipated">May 28, 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>rocuronium plasma concentration (mcg/ml)</measure>
    <time_frame>0, 1, 3, 5, 10, 30, 60, 90, 120 minutes after rocuronium second bolus injection</time_frame>
    <description>PKPD modeling from measuring plasma rocuronium concentration and excreted urine rocuronium amount</description>
  </primary_outcome>
  <primary_outcome>
    <measure>acceleromyography data (TOF ratio %)</measure>
    <time_frame>intraoperative</time_frame>
    <description>Muscle relaxation level (TOF, T1) will be evaluated via acceleromyography. The pharmacodynamic modeling with NONMEM throughout the kidney transplantation.</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">12</enrollment>
  <condition>End Stage Renal Disease</condition>
  <condition>Transplantation</condition>
  <arm_group>
    <arm_group_label>Rocuronium bolus</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>rocuronium bromide 1st bolus 0.1mg/kg, rocuronium bromide 2nd bolus 0.4mg/kg</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Rocuronium bromide</intervention_name>
    <description>Pharmacokinetic-pharmacodynamic modeling blood sampling and Rocuronium bromide concentration measure muscle relaxation evaluation</description>
    <arm_group_label>Rocuronium bolus</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patients scheduled for elective living donor kidney transplantation

          -  end stage renal disease with oliguria or anuria

          -  normal BMI (BMI 18.5 ~ 25)

          -  obtained informed consent

        Exclusion Criteria:

          -  patient with underlying neuromuscular disease
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Chul-Woo Jung, MD. PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Seoul National University Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Chul-Woo Jung, MD. PhD</last_name>
    <phone>82-2-2072-0640</phone>
    <email>spss@dreamwiz.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Eun-Jin Chung, MD</last_name>
    <email>quarkjin@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Seoul National University Hospital</name>
      <address>
        <city>Seoul</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Chul-Woo Jung, MD. PhD</last_name>
      <phone>82-2-2072-2467</phone>
      <email>spss@snuh.org</email>
    </contact>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>April 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 14, 2016</study_first_submitted>
  <study_first_submitted_qc>July 8, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 11, 2016</study_first_posted>
  <last_update_submitted>April 24, 2017</last_update_submitted>
  <last_update_submitted_qc>April 24, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">April 25, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Seoul National University Hospital</investigator_affiliation>
    <investigator_full_name>Chul-Woo Jung</investigator_full_name>
    <investigator_title>Associate professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Kidney Failure, Chronic</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Rocuronium</mesh_term>
    <mesh_term>Bromides</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

